🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 96 of 200 · A–Z by INN

  1. indacaterol + mometasone

    ATECTURA BREEZHALER Novartis Pharmaceuticals

    TGA: approved

  2. indacaterol maleate

    ARCAPTA NEOHALER

    INHALATION FDA: approved

  3. indapamide

    APO-INDAPAMIDE SR Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  4. indecainide hydrochloride

    DECABID

    ORAL FDA: approved

  5. indigotindisulfonate sodium

    BLUDIGO

    INTRAVENOUS FDA: approved

  6. indinavir

    CRIXIVAN

    EMA: withdrawn

    J05AE02

  7. indinavir sulfate

    CRIXIVAN

    ORAL FDA: approved

  8. indium in-111 chloride

    INDICLOR

    INJECTION FDA: approved

  9. indium in-111 oxyquinoline

    INDIUM IN 111 OXYQUINOLINE

    INJECTION FDA: approved

  10. indium in-111 pentetate disodium

    MPI INDIUM DTPA IN 111

    INTRATHECAL FDA: approved

  11. indium in-111 pentetreotide kit

    INDIUM IN-111 PENTETREOTIDE KIT

    INJECTION FDA: approved

  12. individual

    NMPA: clinical trials

  13. indocyanine green

    INDOCYANINE GREEN

    INJECTION FDA: approved

  14. indometacin

    ARTHREXIN Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  15. indomethacin

    INDO-LEMMON Amneal Pharma Europe Ltd

    RECTAL FDA: approved · NMPA: clinical trials

  16. indomethacin sodium

    INDOMETHACIN SODIUM

    INJECTION FDA: approved

  17. induction

    NMPA: clinical trials

  18. inebilizumab

    UPLIZNA

    EMA: approved

    L04AA

  19. inebilizumab-cdon

    UPLIZNA

    INJECTION FDA: approved

  20. infigratinib

    FEBSELTIQ

    EMA: application withdrawn

    L01E

  21. infigratinib phosphate

    TRUSELTIQ

    ORAL FDA: approved

  22. infiltrating

    NMPA: clinical trials

  23. infliximab

    INFLECTRA Pfizer Australia Pty Ltd

    FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AB02

  24. infliximab-abda

    RENFLEXIS

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources